PRFX — PRF Technologies Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1801834 ·
Israel
Last close
$0.66
Market Cap
$2.31M
52W High
$7.95
52W Low
$0.64
ADV30
194,681
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 19,090,000 | 8,526,000 | 2,615,000 |
| Dec 2025 | — | — | — | — | 11,998,000 | 3,125,000 | 2,708,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-64,086,000
Inventory
—
Receivables
$320,000
ST Investments
$3,009,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$31,000
EBITDA
$-4,237,000
Free Cash Flow
$-2,189,750
Enterprise Value
$-8,266,722
Total Cash
$11,535,000
Total Debt
$50,000
Shares Out
3,499,144
Trailing EPS
$-4.09
Book Value
$10.29
ROE
-45.3%
ROA
-21.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 17,000 | -5,122,000 | -5,022,000 | 11,998,000 | 2,708,000 | 8,543,000 | -3,955,000 |
| Dec 2024 | 0 | -14,673,000 | -14,588,000 | 4,525,000 | 2,701,000 | 1,824,000 | -12,621,000 |
| Dec 2023 | 0 | -9,584,000 | -9,344,000 | 9,930,000 | 2,691,000 | 7,239,000 | -6,679,000 |
| Dec 2022 | 0 | -8,869,000 | -8,792,000 | 12,300,000 | 1,310,000 | 11,021,000 | -6,459,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-12.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DCOY | Decoy Therapeutics Inc. | $2.26M | $0.95 | — |
| REVB | REVELATION BIOSCIENCES, INC. | $2.21M | $3.88 | — |
| BDRX | Biodexa Pharmaceuticals Plc | $2.20M | $2.14 | — |
| CVSI | CV Sciences, Inc. | $2.17M | $0.01 | — |
| RDHL | RedHill Biopharma Ltd. | $2.13M | $0.35 | — |
News headlines (Yahoo Finance, 1h cache)
PRF Technologies Receives Nasdaq Delisting Determination Regarding Minimum Bid Price Requirement and Requests a Hearing
2026-11-12 21:05 · Yahoo
PRF Technologies and Dotz Nano Sign Term Sheet for Strategic Collaboration to Expand AI-Driven Energy Optimization Offering
2026-11-03 21:05 · Yahoo
PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing™-K and GridFeed™ Opportunity in AI Data Center Power
2026-10-23 13:06 · Yahoo
PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading Platform
2026-09-09 12:30 · Yahoo
PRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business
2026-09-03 12:30 · Yahoo
PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026
2026-07-21 12:30 · Yahoo
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets
2026-07-15 13:15 · Yahoo
PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World European Market Data
2026-07-08 12:30 · Yahoo
Top Premarket Gainers
2026-05-29 11:16 · Yahoo
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
2026-04-28 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.